Cargando…
The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669604/ https://www.ncbi.nlm.nih.gov/pubmed/38002031 http://dx.doi.org/10.3390/biomedicines11113031 |
_version_ | 1785139735476305920 |
---|---|
author | Donica, Vlad Constantin Alexa, Anisia Iuliana Pavel, Irina Andreea Danielescu, Ciprian Ciapă, Manuela Andreea Donica, Alexandra Lori Bogdănici, Camelia Margareta |
author_facet | Donica, Vlad Constantin Alexa, Anisia Iuliana Pavel, Irina Andreea Danielescu, Ciprian Ciapă, Manuela Andreea Donica, Alexandra Lori Bogdănici, Camelia Margareta |
author_sort | Donica, Vlad Constantin |
collection | PubMed |
description | The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS). |
format | Online Article Text |
id | pubmed-10669604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106696042023-11-11 The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers Donica, Vlad Constantin Alexa, Anisia Iuliana Pavel, Irina Andreea Danielescu, Ciprian Ciapă, Manuela Andreea Donica, Alexandra Lori Bogdănici, Camelia Margareta Biomedicines Review The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS). MDPI 2023-11-11 /pmc/articles/PMC10669604/ /pubmed/38002031 http://dx.doi.org/10.3390/biomedicines11113031 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Donica, Vlad Constantin Alexa, Anisia Iuliana Pavel, Irina Andreea Danielescu, Ciprian Ciapă, Manuela Andreea Donica, Alexandra Lori Bogdănici, Camelia Margareta The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers |
title | The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers |
title_full | The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers |
title_fullStr | The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers |
title_full_unstemmed | The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers |
title_short | The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers |
title_sort | evolvement of oct and oct-a in identifying multiple sclerosis biomarkers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669604/ https://www.ncbi.nlm.nih.gov/pubmed/38002031 http://dx.doi.org/10.3390/biomedicines11113031 |
work_keys_str_mv | AT donicavladconstantin theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT alexaanisiaiuliana theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT pavelirinaandreea theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT danielescuciprian theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT ciapamanuelaandreea theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT donicaalexandralori theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT bogdanicicameliamargareta theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT donicavladconstantin evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT alexaanisiaiuliana evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT pavelirinaandreea evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT danielescuciprian evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT ciapamanuelaandreea evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT donicaalexandralori evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers AT bogdanicicameliamargareta evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers |